Table 1.
Demographic Characteristics—Modified Intent‐to‐Treat Population
| Characteristics | LCPT (N = 29)a | IR‐Tac (N = 29)a | Overall (N = 58)a |
|---|---|---|---|
| Sex, nb (%) | |||
| Male | 24 (82.8) | 16 (55.2) | 40 (69.0) |
| Female | 5 (17.2) | 13 (44.8) | 18 (31.0) |
| Age (y) | |||
| Mean (SD) | 54.1 (7.27) | 54.6 (9.78) | 54.4 (8.55) |
| Median | 55.0 | 55.0 | 55.0 |
| Min‐max | 27–63 | 21–72 | 21–72 |
| Race, nb (%) | |||
| American Indian/Alaska native | 0 (0.0) | 1 (3.4) | 1 (1.7) |
| Asian | 1 (3.4) | 2 (6.9) | 3 (5.2) |
| Asian, native Hawaiian/Pacific Islander | 1 (3.4) | 0 (0.0) | 1 (1.7) |
| Black/African American | 2 (6.9) | 2 (6.9) | 4 (6.9) |
| White | 25 (86.2) | 24 (82.8) | 49 (84.5) |
| Ethnicity, nb (%) | |||
| Hispanic or Latino | 5 (17.2) | 2 (6.9) | 7 (12.1) |
| Not Hispanic or Latino | 24 (82.8) | 27 (93.1) | 51 (87.9) |
IR‐Tac, twice‐daily immediate‐release tacrolimus capsules; LCPT, once‐daily extended‐release tablet formulation of tacrolimus; SD, standard deviation.
a
Percentages based on the total number of patients in the modified intent‐to‐treat analysis data set (N).
b
n represents number of patients contributing to summary.
Source: Table 14.1.2.1, Listing 16.2.4.1.